Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Noa
    Member
    • Jun 2011
    • 62

    Compatability of UCSC NCBI and ENSEMBL genomes

    I ran I ran Cuffdiff using an ENSEMBL genome (rat RGSC3.4) and want to look at my alignments using IGV
    I tried to upload the genome and gtf file I downloaded from ENSEMBL to IGV but it is not working.
    If I upload my bam file to IGV using their rn4 (UCSC version of the rat genome) the alignments seem to match up with the genes. Is this kosher or will I run into problem? How compatible are the different genome versions?

    Also happy to know if anyone has pros/cons of using one vs the other when doing differential expression analyses
    Thanks!
  • mastal
    Senior Member
    • Mar 2009
    • 666

    #2
    I think the genome sequences (rn4 and RGSC3.4) should be the same, but they (UCSC/NCBI/ENSEMBL) all do their own annotations, so you may find differences in the 5' start or 3' end positions of some genes, or in some exons.

    Comment

    • Noa
      Member
      • Jun 2011
      • 62

      #3
      Thanks for the clarification. Any idea what the differences are or how different the different annotations are? Is it worth running cuffdiff with the different annotations or would it all come out the same?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Yesterday, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:10 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...